UniProt ID | SMC5_HUMAN | |
---|---|---|
UniProt AC | Q8IY18 | |
Protein Name | Structural maintenance of chromosomes protein 5 | |
Gene Name | SMC5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1101 | |
Subcellular Localization | Nucleus . Chromosome . Nucleus, PML body . Chromosome, telomere . Associates with chromatin (PubMed:25931565). Colocalizes with SMC6 on the X-Y chromosome pair within the sex vesicle during late pachytene/diplotene (By similarity). Localizes to PML n | |
Protein Description | Core component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines and mediates sumoylation of shelterin complex (telosome) components which is proposed to lead to shelterin complex disassembly in ALT-associated PML bodies (APBs). Required for recruitment of telomeres to PML nuclear bodies. Required for sister chromatid cohesion during prometaphase and mitotic progression; the function seems to be independent of SMC6. SMC5-SMC6 complex may prevent transcription of episomal DNA, such as circular viral DNA genome. [PubMed: 26983541] | |
Protein Sequence | MATPSKKTSTPSPQPSKRALPRDPSSEVPSKRKNSAPQLPLLQSSGPFVEGSIVRISMENFLTYDICEVSPGPHLNMIVGANGTGKSSIVCAICLGLAGKPAFMGRADKVGFFVKRGCSRGMVEIELFRASGNLVITREIDVAKNQSFWFINKKSTTQKIVEEKVAALNIQVGNLCQFLPQDKVGEFAKLSKIELLEATEKSIGPPEMHKYHCELKNLREKEKQLETSCKEKTEYLQKMVQRNERYKQDVERFYERKRHLDLIEMLEAKRPWVEYENVRQEYEEVKLVRDRVKEEVRKLKEGQIPVTCRIEEMENERHNLEARIKEKATDIKEASQKCKQKQDVIERKDKHIEELQQALIVKQNEELDRQRRIGNTRKMIEDLQNELKTTENCENLQPQIDAITNDLRRIQDEKALCEGEIIDKRRERETLEKEKKSVDDHIVRFDNLMNQKEDKLRQRFRDTYDAVLWLRNNRDKFKQRVCEPIMLTINMKDNKNAKYIENHIPSNDLRAFVFESQEDMEVFLKEVRDNKKLRVNAVIAPKSSYADKAPSRSLNELKQYGFFSYLRELFDAPDPVMSYLCCQYHIHEVPVGTEKTRERIERVIQETRLKQIYTAEEKYVVKTSFYSNKVISSNTSLKVAQFLTVTVDLEQRRHLEEQLKEIHRKLQAVDSGLIALRETSKHLEHKDNELRQKKKELLERKTKKRQLEQKISSKLGSLKLMEQDTCNLEEEERKASTKIKEINVQKAKLVTELTNLIKICTSLHIQKVDLILQNTTVISEKNKLESDYMAASSQLRLTEQHFIELDENRQRLLQKCKELMKRARQVCNLGAEQTLPQEYQTQVPTIPNGHNSSLPMVFQDLPNTLDEIDALLTEERSRASCFTGLNPTIVQEYTKREEEIEQLTEELKGKKVELDQYRENISQVKERWLNPLKELVEKINEKFSNFFSSMQCAGEVDLHTENEEDYDKYGIRIRVKFRSSTQLHELTPHHQSGGERSVSTMLYLMALQELNRCPFRVVDEINQGMDPINERRVFEMVVNTACKENTSQYFFITPKLLQNLPYSEKMTVLFVYNGPHMLEPNTWNLKAFQRRRRRITFTQPS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MATPSKKTSTPSPQP CCCCCCCCCCCCCCC | 41.38 | 27794612 | |
9 | Phosphorylation | ATPSKKTSTPSPQPS CCCCCCCCCCCCCCC | 47.39 | 27794612 | |
10 | Phosphorylation | TPSKKTSTPSPQPSK CCCCCCCCCCCCCCC | 32.77 | 26055452 | |
12 | Phosphorylation | SKKTSTPSPQPSKRA CCCCCCCCCCCCCCC | 35.93 | 23401153 | |
16 | Phosphorylation | STPSPQPSKRALPRD CCCCCCCCCCCCCCC | 29.53 | 27794612 | |
17 | Acetylation | TPSPQPSKRALPRDP CCCCCCCCCCCCCCC | 48.66 | 25953088 | |
25 | Phosphorylation | RALPRDPSSEVPSKR CCCCCCCCCCCCCCC | 43.34 | 25159151 | |
26 | Phosphorylation | ALPRDPSSEVPSKRK CCCCCCCCCCCCCCC | 48.26 | 21815630 | |
30 | Phosphorylation | DPSSEVPSKRKNSAP CCCCCCCCCCCCCCC | 50.71 | 21815630 | |
31 | Acetylation | PSSEVPSKRKNSAPQ CCCCCCCCCCCCCCC | 62.41 | 25953088 | |
31 | Ubiquitination | PSSEVPSKRKNSAPQ CCCCCCCCCCCCCCC | 62.41 | - | |
35 | Phosphorylation | VPSKRKNSAPQLPLL CCCCCCCCCCCCCCC | 44.34 | 25159151 | |
44 | Phosphorylation | PQLPLLQSSGPFVEG CCCCCCCCCCCCCCC | 36.91 | 23927012 | |
45 | Phosphorylation | QLPLLQSSGPFVEGS CCCCCCCCCCCCCCC | 37.21 | 23927012 | |
52 | Phosphorylation | SGPFVEGSIVRISME CCCCCCCCEEEEECC | 12.38 | 23898821 | |
100 | Ubiquitination | ICLGLAGKPAFMGRA HHHHHCCCCHHCCCC | 27.80 | - | |
109 | Acetylation | AFMGRADKVGFFVKR HHCCCCHHHEEEEEC | 43.18 | 30592491 | |
109 | Ubiquitination | AFMGRADKVGFFVKR HHCCCCHHHEEEEEC | 43.18 | - | |
115 | Acetylation | DKVGFFVKRGCSRGM HHHEEEEECCCCCCC | 37.61 | 30592497 | |
115 | Ubiquitination | DKVGFFVKRGCSRGM HHHEEEEECCCCCCC | 37.61 | - | |
120 | Ubiquitination | FVKRGCSRGMVEIEL EEECCCCCCCEEEEE | 41.10 | 22505724 | |
142 | Ubiquitination | VITREIDVAKNQSFW EEEEEEEECCCCCEE | 11.39 | 23000965 | |
157 | Phosphorylation | FINKKSTTQKIVEEK EEECCCCCHHHHHHH | 34.65 | - | |
159 | Ubiquitination | NKKSTTQKIVEEKVA ECCCCCHHHHHHHHH | 46.78 | - | |
180 | Ubiquitination | GNLCQFLPQDKVGEF CCHHHHCCCCCHHHH | 41.43 | 23000965 | |
183 | Ubiquitination | CQFLPQDKVGEFAKL HHHCCCCCHHHHHHH | 47.06 | 23000965 | |
189 | Ubiquitination | DKVGEFAKLSKIELL CCHHHHHHHHHHHHH | 59.62 | 23000965 | |
192 | Ubiquitination | GEFAKLSKIELLEAT HHHHHHHHHHHHHHH | 51.11 | 23000965 | |
199 | Phosphorylation | KIELLEATEKSIGPP HHHHHHHHHHHCCCH | 34.27 | 20068231 | |
210 | Ubiquitination | IGPPEMHKYHCELKN CCCHHHHHHHHHHHH | 35.07 | 29967540 | |
216 | Acetylation | HKYHCELKNLREKEK HHHHHHHHHHHHHHH | 31.48 | 26051181 | |
216 | Ubiquitination | HKYHCELKNLREKEK HHHHHHHHHHHHHHH | 31.48 | 29967540 | |
227 | Phosphorylation | EKEKQLETSCKEKTE HHHHHHHHHHHHHHH | 48.28 | 29083192 | |
228 | Phosphorylation | KEKQLETSCKEKTEY HHHHHHHHHHHHHHH | 17.51 | 29083192 | |
232 | Ubiquitination | LETSCKEKTEYLQKM HHHHHHHHHHHHHHH | 31.95 | - | |
233 | Phosphorylation | ETSCKEKTEYLQKMV HHHHHHHHHHHHHHH | 30.84 | 29083192 | |
235 | Phosphorylation | SCKEKTEYLQKMVQR HHHHHHHHHHHHHHH | 21.47 | 29083192 | |
238 | Ubiquitination | EKTEYLQKMVQRNER HHHHHHHHHHHHCHH | 38.14 | 21906983 | |
254 | Phosphorylation | KQDVERFYERKRHLD HHHHHHHHHHHHHHH | 22.50 | 26657352 | |
269 | Ubiquitination | LIEMLEAKRPWVEYE HHHHHHHCCCCCCEE | 50.01 | 29967540 | |
275 | Phosphorylation | AKRPWVEYENVRQEY HCCCCCCEEHHHHHH | 11.81 | - | |
282 | Phosphorylation | YENVRQEYEEVKLVR EEHHHHHHHHHHHHH | 14.73 | - | |
286 | Acetylation | RQEYEEVKLVRDRVK HHHHHHHHHHHHHHH | 44.54 | 25953088 | |
286 | Ubiquitination | RQEYEEVKLVRDRVK HHHHHHHHHHHHHHH | 44.54 | 33845483 | |
300 | Ubiquitination | KEEVRKLKEGQIPVT HHHHHHHHCCCCCCE | 63.93 | 29967540 | |
329 | Phosphorylation | ARIKEKATDIKEASQ HHHHHHCHHHHHHHH | 49.69 | 29396449 | |
350 | Ubiquitination | DVIERKDKHIEELQQ HHHHHHHHHHHHHHH | 49.90 | 29967540 | |
362 | Acetylation | LQQALIVKQNEELDR HHHHHHHHCHHHHHH | 40.17 | 25953088 | |
362 | Ubiquitination | LQQALIVKQNEELDR HHHHHHHHCHHHHHH | 40.17 | 29967540 | |
378 | Ubiquitination | RRIGNTRKMIEDLQN HHHCHHHHHHHHHHH | 42.04 | 29967540 | |
405 | Ubiquitination | PQIDAITNDLRRIQD HHHHHHHHHHHHHHH | 39.96 | 24816145 | |
414 | Acetylation | LRRIQDEKALCEGEI HHHHHHHHHHHCCCC | 55.75 | 26051181 | |
414 | Ubiquitination | LRRIQDEKALCEGEI HHHHHHHHHHHCCCC | 55.75 | 29967540 | |
424 | Ubiquitination | CEGEIIDKRRERETL HCCCCCCHHHHHHHH | 42.84 | 29967540 | |
436 | Ubiquitination | ETLEKEKKSVDDHIV HHHHHHHHCHHHHHH | 57.72 | 29967540 | |
443 | Ubiquitination | KSVDDHIVRFDNLMN HCHHHHHHHHHHHHC | 4.47 | 24816145 | |
452 | Ubiquitination | FDNLMNQKEDKLRQR HHHHHCHHHHHHHHH | 63.98 | 32015554 | |
455 | Acetylation | LMNQKEDKLRQRFRD HHCHHHHHHHHHHHH | 46.81 | 26051181 | |
455 | Ubiquitination | LMNQKEDKLRQRFRD HHCHHHHHHHHHHHH | 46.81 | 29967540 | |
474 | Ubiquitination | VLWLRNNRDKFKQRV HHHHHCCHHHHHHHH | 52.63 | 22505724 | |
492 | Ubiquitination | IMLTINMKDNKNAKY EEEEEECCCCCCCCH | 54.37 | - | |
495 | Ubiquitination | TINMKDNKNAKYIEN EEECCCCCCCCHHHH | 69.30 | - | |
498 | Ubiquitination | MKDNKNAKYIENHIP CCCCCCCCHHHHCCC | 57.04 | 22505724 | |
506 | Phosphorylation | YIENHIPSNDLRAFV HHHHCCCCCHHHHHE | 42.23 | 25159151 | |
520 | Ubiquitination | VFESQEDMEVFLKEV EECCHHHHHHHHHHH | 4.68 | 23000965 | |
534 | Ubiquitination | VRDNKKLRVNAVIAP HHCCCCEEEEEEECC | 28.64 | 23000965 | |
542 | Ubiquitination | VNAVIAPKSSYADKA EEEEECCCCHHCCCC | 42.91 | 33845483 | |
548 | Acetylation | PKSSYADKAPSRSLN CCCHHCCCCCCCCHH | 54.76 | 19608861 | |
548 | Ubiquitination | PKSSYADKAPSRSLN CCCHHCCCCCCCCHH | 54.76 | 19608861 | |
558 | Ubiquitination | SRSLNELKQYGFFSY CCCHHHHHHCCHHHH | 34.98 | 23000965 | |
560 | Phosphorylation | SLNELKQYGFFSYLR CHHHHHHCCHHHHHH | 17.82 | 21406692 | |
564 | Phosphorylation | LKQYGFFSYLRELFD HHHCCHHHHHHHHHC | 22.46 | 21406692 | |
565 | Phosphorylation | KQYGFFSYLRELFDA HHCCHHHHHHHHHCC | 12.48 | 21406692 | |
595 | Ubiquitination | EVPVGTEKTRERIER ECCCCCHHHHHHHHH | 53.36 | - | |
610 | Malonylation | VIQETRLKQIYTAEE HHHHHHHHHHCCCCC | 31.21 | 26320211 | |
610 | Ubiquitination | VIQETRLKQIYTAEE HHHHHHHHHHCCCCC | 31.21 | 33845483 | |
614 | Phosphorylation | TRLKQIYTAEEKYVV HHHHHHCCCCCEEEE | 29.26 | 30242111 | |
618 | Acetylation | QIYTAEEKYVVKTSF HHCCCCCEEEEEEEE | 34.55 | 26051181 | |
618 | Ubiquitination | QIYTAEEKYVVKTSF HHCCCCCEEEEEEEE | 34.55 | 29967540 | |
619 | Phosphorylation | IYTAEEKYVVKTSFY HCCCCCEEEEEEEEC | 17.47 | - | |
626 | Phosphorylation | YVVKTSFYSNKVISS EEEEEEECCCCEECC | 15.88 | 25884760 | |
629 | Ubiquitination | KTSFYSNKVISSNTS EEEECCCCEECCCCC | 34.70 | 29967540 | |
665 | Ubiquitination | QLKEIHRKLQAVDSG HHHHHHHHHHHHHHH | 30.68 | 29967540 | |
671 | Phosphorylation | RKLQAVDSGLIALRE HHHHHHHHHHHHHHH | 28.97 | 22210691 | |
686 | Acetylation | TSKHLEHKDNELRQK HHHHHCCHHHHHHHH | 53.53 | 25953088 | |
714 | Acetylation | LEQKISSKLGSLKLM HHHHHHHHHHHHHHH | 50.50 | 25953088 | |
714 | Ubiquitination | LEQKISSKLGSLKLM HHHHHHHHHHHHHHH | 50.50 | 29967540 | |
719 | Ubiquitination | SSKLGSLKLMEQDTC HHHHHHHHHHHCCCC | 47.70 | 32015554 | |
740 | Ubiquitination | RKASTKIKEINVQKA HHHHHHHHHHHHHHH | 54.84 | - | |
746 | Ubiquitination | IKEINVQKAKLVTEL HHHHHHHHHHHHHHH | 43.11 | - | |
748 | Acetylation | EINVQKAKLVTELTN HHHHHHHHHHHHHHH | 50.99 | 25953088 | |
748 | Ubiquitination | EINVQKAKLVTELTN HHHHHHHHHHHHHHH | 50.99 | - | |
751 | Phosphorylation | VQKAKLVTELTNLIK HHHHHHHHHHHHHHH | 35.40 | 22817900 | |
754 | Phosphorylation | AKLVTELTNLIKICT HHHHHHHHHHHHHHH | 23.03 | 22817900 | |
779 | Phosphorylation | LQNTTVISEKNKLES EECCEECCCCCCCCH | 37.88 | 18491316 | |
783 | Ubiquitination | TVISEKNKLESDYMA EECCCCCCCCHHHHH | 65.78 | 24816145 | |
786 | Phosphorylation | SEKNKLESDYMAASS CCCCCCCHHHHHHHH | 44.47 | 30576142 | |
788 | Phosphorylation | KNKLESDYMAASSQL CCCCCHHHHHHHHHH | 9.64 | 20873877 | |
792 | Phosphorylation | ESDYMAASSQLRLTE CHHHHHHHHHHHHHH | 14.74 | 25159151 | |
793 | Phosphorylation | SDYMAASSQLRLTEQ HHHHHHHHHHHHHHH | 28.62 | 25159151 | |
797 | Ubiquitination | AASSQLRLTEQHFIE HHHHHHHHHHHHHHH | 9.33 | 24816145 | |
821 | Ubiquitination | QKCKELMKRARQVCN HHHHHHHHHHHHHHH | 56.37 | 24816145 | |
895 | Ubiquitination | TIVQEYTKREEEIEQ HHHHHHHHCHHHHHH | 57.84 | - | |
908 | Ubiquitination | EQLTEELKGKKVELD HHHHHHHCCCCCCHH | 72.47 | 32015554 | |
911 | Ubiquitination | TEELKGKKVELDQYR HHHHCCCCCCHHHHH | 50.00 | 29967540 | |
925 | Ubiquitination | RENISQVKERWLNPL HHHHHHHHHHHHHHH | 33.65 | 29967540 | |
933 | Ubiquitination | ERWLNPLKELVEKIN HHHHHHHHHHHHHHH | 50.70 | 29967540 | |
979 | Phosphorylation | RIRVKFRSSTQLHEL EEEEEECCCCCCEEC | 40.65 | 20873877 | |
980 | Phosphorylation | IRVKFRSSTQLHELT EEEEECCCCCCEECC | 18.86 | 28555341 | |
981 | Phosphorylation | RVKFRSSTQLHELTP EEEECCCCCCEECCC | 36.07 | 28555341 | |
987 | Phosphorylation | STQLHELTPHHQSGG CCCCEECCCCCCCCC | 20.00 | 22067460 | |
1025 | Sulfoxidation | VDEINQGMDPINERR HCHHHCCCCCCCHHH | 3.89 | 21406390 | |
1046 | Phosphorylation | NTACKENTSQYFFIT CHHHHCCCCCEEEEC | 20.49 | - | |
1047 | Phosphorylation | TACKENTSQYFFITP HHHHCCCCCEEEECH | 34.17 | - | |
1062 | Phosphorylation | KLLQNLPYSEKMTVL HHHCCCCCCCCEEEE | 32.40 | - | |
1096 | Phosphorylation | QRRRRRITFTQPS-- HHHHHCCEEECCC-- | 20.86 | 23312004 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SMC5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SMC5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SMC6_HUMAN | SMC6 | physical | 11408570 | |
NSE2_HUMAN | NSMCE2 | physical | 16055714 | |
NSE1_HUMAN | NSMCE1 | physical | 16055714 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-548, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY. |